Literature DB >> 11025626

Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.

A Ravikumar1, K V Deepadevi, P Arun, V Manojkumar, P A Kurup.   

Abstract

Catabolism of tryptophan and tyrosine in relation to the isoprenoid pathway was studied in neurological and psychiatric disorders. The concentration of trytophan, quinolinic acid, kynurenic acid, serotonin and 5-hydroxyindoleacetic acid was found to be higher in the plasma of patients with all these disorders; while that of tyrosine, dopamine, epinephrine and norepinephrine was lower. There was increase in free fatty acids and decrease in albumin (factors modulating tryptophan transport) in the plasma of these patients. Concentration of digoxin, a modulator of amino acid transport, and the activity of HMG CoA reductase, which synthesizes digoxin, were higher in these patients; while RBC membrane Na+-K+ ATPase activity showed a decrease. Concentration of plasma ubiquinone (part of which is synthesised from tyrosine) and magnesium was also lower in these patients. No morphine could be detected in the plasma of these patients except in MS. On the other hand, strychnine and nicotine were detectable. These results indicate hypercatabolism of tryptophan and hypocatabolism of tyrosine in these disorders, which could be a consequence of the modulating effect of hypothalamic digoxin on amino acid transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11025626

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  16 in total

Review 1.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

2.  Kynurenine is correlated with IL-1β in plasma of schizophrenia patients.

Authors:  Helena P G Joaquim; Alana C Costa; Wagner F Gattaz; Leda Leme Talib
Journal:  J Neural Transm (Vienna)       Date:  2018-01-06       Impact factor: 3.575

Review 3.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Jun Ku Chung; Philip Gerretsen; Julia Kim; Hiroyoshi Takeuchi; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.

Authors:  Alexandre K Wang; Brian J Miller
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

5.  The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.

Authors:  Abbas F Almulla; Asara Vasupanrajit; Chavit Tunvirachaisakul; Hussein K Al-Hakeim; Marco Solmi; Robert Verkerk; Michael Maes
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 15.992

6.  Isoprenoid pathway related cascade in multiple myeloma.

Authors:  Ravi kumar Kurup; Rekha A Nair; Parameswara Achutha Kurup
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

Review 7.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

Review 8.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

10.  Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathology.

Authors:  Anna Kubesova; Hana Tejkalova; Kamila Syslova; Petr Kacer; Jana Vondrousova; Filip Tyls; Michaela Fujakova; Tomas Palenicek; Jiri Horacek
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.